000 | 01182 a2200349 4500 | ||
---|---|---|---|
005 | 20250513025810.0 | ||
264 | 0 | _c19951207 | |
008 | 199512s 0 0 eng d | ||
022 | _a0033-3158 | ||
024 | 7 |
_a10.1007/BF02246184 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoffman, D C | |
245 | 0 | 0 |
_aCatalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. _h[electronic resource] |
260 |
_bPsychopharmacology _cJul 1995 |
||
300 |
_a128-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmphetamine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
650 | 0 | 4 |
_aCatalepsy _xdrug therapy |
650 | 0 | 4 |
_aClozapine _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aExtrapyramidal Tracts _xdrug effects |
650 | 0 | 4 |
_aLocomotion _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aDonovan, H | |
773 | 0 |
_tPsychopharmacology _gvol. 120 _gno. 2 _gp. 128-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02246184 _zAvailable from publisher's website |
999 |
_c7480014 _d7480014 |